Hanoulle-Titeca SRL
Hanoulle-Titeca reported total assets of €1.37m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of Hanoulle-Titeca shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +12 % Total assets +7 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hanoulle-Titeca's annual accounts
Filed annual accounts
- Year ended 30 Nov 2025filed on 30 Jun 2026
- Year ended 30 Nov 2024filed on 30 Jun 2025
- Year ended 30 Nov 2023filed on 01 Jul 2024
- Year ended 30 Nov 2022filed on 20 Jun 2023
- Year ended 30 Nov 2021filed on 28 Jun 2022
Hanoulle-Titeca's financial analysis
- Solvency64.3%sector median: 47.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hanoulle-Titeca
Hanoulle-Titeca's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0476.972.853
- VAT number
- BE0476972853
- Peppol
- Registered · 0208:0476972853 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Feb 2002
- Registered office
- 8800 Roeselare
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
Hanoulle-Titeca (SRL) has been based in Roeselare since 2002, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports a net loss of 9,595 € and equity of 879,282 €; its revenue is not published. Its solvency stands at 64.3%, above the median of its sector (47.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Hanoulle-Titeca
Companies in the same business, of comparable size and area, outside its group.
- Chemliro Retail sale of medical and orthopaedic goods Roeselare · balance sheet 67,557 €
- QUALIAS Namur BW Retail sale of medical and orthopaedic goods Namur · balance sheet €1.39m
- Pro-Audio Retail sale of medical and orthopaedic goods Antwerp · balance sheet €1.16m
- UCMI Retail sale of medical and orthopaedic goods Liège · balance sheet €1.25m
- Decover Retail sale of medical and orthopaedic goods Waregem · balance sheet €2.65m
- Hears2U Retail sale of medical and orthopaedic goods Kortenberg · balance sheet €1.07m
- Bellini Clinic Retail sale of medical and orthopaedic goods Bree · balance sheet 486,442 €
- Braem Martine Retail sale of medical and orthopaedic goods Heuvelland · balance sheet €2.03m
Frequently asked questions about Hanoulle-Titeca
What is the revenue of Hanoulle-Titeca?
Hanoulle-Titeca files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hanoulle-Titeca?
In Belgium, the VAT number is the company number prefixed with BE: BE0476972853 for Hanoulle-Titeca, if the company is VAT-registered. Its company number (CBE) is 0476.972.853.
Where is the registered office of Hanoulle-Titeca?
According to the CBE register, the registered office of Hanoulle-Titeca is in 8800 Roeselare.
What is the equity of Hanoulle-Titeca?
At the close of the 2025 financial year, the equity of Hanoulle-Titeca amounts to 879,282 €, a solvency of 64.3% of total assets.
Who manages Hanoulle-Titeca?
The register lists 2 active mandates at Hanoulle-Titeca. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hanoulle-Titeca
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →